Press Releases from Provecs Medical (2 total)
Provecs Medical Announces Publication of Scientific Review of Gene Therapy in On …
-- Peer-reviewed paper in Human Gene Therapy provides comprehensive overview of using gene therapy to address multiple targets --
Hamburg (December 14, 2017) - Provecs Medical GmbH, a cancer immunotherapy company developing novel treatments to modulate the tumor microenvironment, today announced the publication of a review highlighting the use of gene therapy approaches in immuno-oncology to address multiple targets with a single drug. The paper entitled “Immuno-Oncology - the Translational Runway…
Provecs Medical closes immuno-oncology collaboration with Medac
- Joint development of Immunalon® in urinary bladder cancer
Hamburg (16 03 2017) - Provecs Medical GmbH, a cancer immunotherapy company developing novel treatments to modulate the tumor microenvironment, today announced the closing of a partnership with oncology pharma company Medac Gesellschaft für klinische Spezialpräparate mbH. The partners aim to develop, manufacture and market Provec’s cancer immunotherapy lead product Immunalon® for the treatment of urinary bladder cancer. Immunalon® is being developed…
